Welsh Carson discloses 74.3% stake in Lumexa
Rhea-AI Filing Summary
Welsh, Carson, Anderson & Stowe entities report majority ownership of Lumexa Imaging Holdings, Inc. The reporting group, through Lumexa Imaging Holdings, LLC, beneficially owns 70,217,616 shares of Lumexa common stock, representing 74.3% of the company’s outstanding shares.
These percentages are based on 94,565,652 shares of common stock outstanding after Lumexa’s initial public offering, as stated in the company’s final prospectus. The ownership is shared among Welsh, Carson, Anderson & Stowe XII, L.P., WCAS XII Associates LLC, and WCAS Management Corporation, reflecting their control and investment advisory roles.
After a 180-day lock-up period following the December 12, 2025 IPO closing, Lumexa Imaging Holdings, LLC may distribute its shares to equity holders on a pro rata basis. Up to 28,595,386 shares could be received by various Welsh, Carson, Anderson & Stowe affiliates in a full distribution, while remaining shares would go to unaffiliated holders, reducing the group’s shared beneficial ownership.
Positive
- None.
Negative
- None.
Insights
Filing shows a controlling 74.3% stake in Lumexa held by WCAS affiliates.
The report indicates that Welsh, Carson, Anderson & Stowe XII, L.P. and related entities beneficially own 70,217,616 Lumexa shares, or 74.3% of the common stock, via Lumexa Imaging Holdings, LLC. This establishes clear majority control by a single sponsor group.
Percentage ownership is calculated against 94,565,652 shares outstanding after the initial public offering, as disclosed in Lumexa’s final prospectus on Form 424B4 dated December 10, 2025. The filing clarifies voting and dispositive power is shared among the reporting entities through their governance rights over the holding LLC.
The structure allows a potential pro rata distribution after a 180-day lock-up following the December 12, 2025 IPO closing. In a full distribution, up to 28,595,386 shares could be allocated to specified WCAS-related funds and vehicles, with remaining shares going to unaffiliated holders. Future distributions, if made, would change how control and beneficial ownership are recorded, but actual impact will depend on any distribution decisions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Lumexa Imaging Holdings (LMRI) does the Welsh, Carson group control?
Which entities are the reporting persons in the Lumexa (LMRI) Schedule 13G filing?
How is the Welsh, Carson ownership in Lumexa (LMRI) structured?
What happens to Welsh, Carson’s Lumexa (LMRI) stake after the IPO lock-up period?
AI-generated analysis. How Rhea-AI works. Not financial advice.